scispace - formally typeset
G

Gang Ning

Researcher at Harvard University

Publications -  21
Citations -  1135

Gang Ning is an academic researcher from Harvard University. The author has contributed to research in topics: Serous fluid & Oocyte. The author has an hindex of 15, co-authored 21 publications receiving 943 citations. Previous affiliations of Gang Ning include Brigham and Women's Hospital & University of Minnesota.

Papers
More filters
Journal ArticleDOI

Iron addiction: a novel therapeutic target in ovarian cancer

TL;DR: The iron dependence of ovarian cancer TICs renders them exquisitely sensitive in vivo to agents that induce iron-dependent cell death (ferroptosis) as well as iron chelators, and thus creates a metabolic vulnerability that can be exploited therapeutically.
Journal ArticleDOI

Cloning and variation of ground state intestinal stem cells

TL;DR: The cloning and propagation of highly clonogenic, ‘ground state’ stem cells of the human intestine and colon are demonstrated and the stability of the epigenetic commitment programs of these stem cells, coupled with their unlimited replicative expansion and maintained clonogenicity, suggests certain advantages for their use in disease modelling and regenerative medicine.
Journal ArticleDOI

Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube†

TL;DR: This study reveals, for the first time, an entity (SCOUT) that is associated with serous cancer, expands the topography of altered PAX2 expression in the female genital tract mucosa and highlights another potential pathway disturbance involved in early serous carcinogenesis in the Fallopian tube.
Journal ArticleDOI

A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.

TL;DR: This review addresses 4 categories of tubal epithelial change: metaplasias; nonmalignant atypias; potential precursors, including secretory cell outgrowths and p53 signatures; and tubal intraepithelial carcinomas.
Journal ArticleDOI

Through the glass darkly: intraepithelial neoplasia, top‐down differentiation, and the road to ovarian cancer

TL;DR: Resolving this question will require accurately distinguishing progenitor from progeny tumour cells in HGSC and pinpointing where initial transformation and trans‐differentiation occur, whether in the tube or POSE, are critical to expectations from prophylactic salpingectomy and future approaches to pelvic serous cancer prevention.